These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27764522)

  • 1. Combination of acid phosphatase positivity and rimmed vacuoles as useful markers in the diagnosis of adult-onset Pompe disease lacking specific clinical and pathological features.
    Dolfus C; Simon JP; Landemore G; Leroy F; Chapon F
    Folia Neuropathol; 2016; 54(3):295-302. PubMed ID: 27764522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acid phosphatase-positive globular inclusions is a good diagnostic marker for two patients with adult-onset Pompe disease lacking disease specific pathology.
    Tsuburaya RS; Monma K; Oya Y; Nakayama T; Fukuda T; Sugie H; Hayashi YK; Nonaka I; Nishino I
    Neuromuscul Disord; 2012 May; 22(5):389-93. PubMed ID: 22196155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle biopsy in Pompe disease.
    Werneck LC; Lorenzoni PJ; Kay CS; Scola RH
    Arq Neuropsiquiatr; 2013 May; 71(5):284-9. PubMed ID: 23689405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients.
    Feeney EJ; Austin S; Chien YH; Mandel H; Schoser B; Prater S; Hwu WL; Ralston E; Kishnani PS; Raben N
    Acta Neuropathol Commun; 2014 Jan; 2():2. PubMed ID: 24383498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vacuolated PAS-positive lymphocytes as an hallmark of Pompe disease and other myopathies related to impaired autophagy.
    Pascarella A; Terracciano C; Farina O; Lombardi L; Esposito T; Napolitano F; Franzese G; Panella G; Tuccillo F; la Marca G; Bernardini S; Boffo S; Giordano A; Di Iorio G; Melone MAB; Sampaolo S
    J Cell Physiol; 2018 Aug; 233(8):5829-5837. PubMed ID: 29215735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of vacuolar muscle biopsies: use of p62, LC3 and LAMP2 immunohistochemistry.
    Vittonatto E; Boschi S; CHIADò-Piat L; Ponzalino V; Bortolani S; Brusa C; Rainero I; Ricci F; Vercelli L; Mongini T
    Acta Myol; 2017 Dec; 36(4):191-198. PubMed ID: 29770361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy.
    Golsari A; Nasimzadah A; Thomalla G; Keller S; Gerloff C; Magnus T
    Neuromuscul Disord; 2018 Mar; 28(3):257-261. PubMed ID: 29326002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periodic acid-Schiff staining on resin muscle sections: improvement in the histological diagnosis of late-onset Pompe disease.
    Terracciano C; Rastelli E; Massa R
    Muscle Nerve; 2012 Apr; 45(4):611-2. PubMed ID: 22431097
    [No Abstract]   [Full Text] [Related]  

  • 9. [A retrospective study of six patients with late-onset Pompe disease].
    Saux A; Laforet P; Pagès AM; Figarella-Branger D; Pellissier JF; Pagès M; Labauge P
    Rev Neurol (Paris); 2008 Apr; 164(4):336-42. PubMed ID: 18439925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic muscle fiber degeneration in distal myopathy with rimmed vacuoles.
    Yan C; Ikezoe K; Nonaka I
    Acta Neuropathol; 2001 Jan; 101(1):9-16. PubMed ID: 11194945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluating Muscle Biopsies in the Diagnosis of Pompe Disease: A Corroborative Report.
    Genge A; Campbell N
    Can J Neurol Sci; 2016 Jul; 43(4):561-6. PubMed ID: 27039993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical sequelae of 17 cases with glycogen storage disease type II/Pompe disease].
    Zhang HB; Zhang WM; Qiu JJ; Meng Y; Qiu ZQ
    Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):415-9. PubMed ID: 22931935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rimmed basophilic vacuoles and filamentous inclusions in neuromuscular disorders.
    Jongen PJ; Ter Laak HJ; Stadhouders AM
    Neuromuscul Disord; 1995 Jan; 5(1):31-8. PubMed ID: 7719139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pompe disease: An Indian series diagnosed on muscle biopsy by ultrastructural characterization.
    Kakkar A; Sharma MC; Nambirajan A; Gulati S; Bhatia R; Suri V; Sarkar C
    Ultrastruct Pathol; 2018; 42(3):211-219. PubMed ID: 29565761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vacuolar changes in neuromuscular disorders: a morphometric study.
    Lee CC; Huang CC; Chen SS
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Dec; 56(6):386-92. PubMed ID: 8851479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathology of skeletal muscle cells in adult-onset glycogenosis type II (Pompe disease): ultrastructural study.
    Lewandowska E; Wierzba-Bobrowicz T; Rola R; Modzelewska J; Stepień T; Lugowska A; Pasennik E; Ryglewicz D
    Folia Neuropathol; 2008; 46(2):123-33. PubMed ID: 18587706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late-onset autosomal recessive limb-girdle muscular dystrophy with rimmed vacuoles.
    Nakamura A; Yoshida K; Ikeda S
    Clin Neurol Neurosurg; 2004 Mar; 106(2):122-8. PubMed ID: 15003303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late onset glycogen storage disease type II with reducing body-like inclusions.
    Gayathri N; Yasha TC; Vani S; Taly AB; Nalini A; Shankar SK
    Clin Neuropathol; 2010; 29(1):36-40. PubMed ID: 20040332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Pompe disease: muscle biopsy vs blood-based assays.
    Vissing J; Lukacs Z; Straub V
    JAMA Neurol; 2013 Jul; 70(7):923-7. PubMed ID: 23649721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of muscle pathology in infantile Pompe disease.
    Schänzer A; Kaiser AK; Mühlfeld C; Kulessa M; Paulus W; von Pein H; Rohrbach M; Viergutz L; Mengel E; Marquardt T; Neubauer B; Acker T; Hahn A
    Neuromuscul Disord; 2017 Feb; 27(2):141-152. PubMed ID: 27927596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.